ArticleInflammation2024

Multiple gene-drug prediction tool reveals Rosiglitazone based treatment pathway for non-segmental vitiligo.

Sijia Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.